Assertion: severe rheumatoid arthritis | /r/HasProperty | ra
Facets:
Source sentences:
text: On August 16, 2019, the U.S. Food and Drug Administration (FDA) approved upadacitinib (Rinvoq), an oral medication for adults with moderate to severe rheumatoid arthritis (RA) that is not being well-controlled by methotrexate.
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: INDICATIONS Moderate to Severe Rheumatoid Arthritis (RA)
text: Moderate to Severe Rheumatoid Arthritis (RA)
text: Moderate to Severe Rheumatoid Arthritis (RA)